Ocapan, Maria .

HRN: 23-56-83  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2023
AMPICILLIN 1GM (VIAL)
12/20/2023
12/21/2023
IV
2gm
Q6
PROM
Waiting Final Action 
12/20/2023
METRONIDAZOLE 500MG (TAB)
12/20/2023
12/26/2023
PO
500mg
TID
Thickly Msaf
Waiting Final Action 
12/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/20/2023
12/20/2023
IV
500mg
On Call To OR
Preop Prophylaxis
Waiting Final Action 
12/20/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
12/20/2023
12/22/2023
IV
500mg
Q8hrs X 3 Doses
S/P Primary LSTCS; Thickly MSAF
Waiting Final Action 
12/21/2023
CO-AMOXICLAV 625MG (TAB)
12/21/2023
12/28/2023
PO
625 Mg
BID
Post OP Prophylaxis
Waiting Final Action 
12/21/2023
METRONIDAZOLE 500MG (TAB)
12/21/2023
12/28/2023
PO
500mg Tab
TID
Post OP Prophylaxis
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: